Company Overview

Update
Founded:
2007
Founders:
Chris Torrance, Dan Cowell
Employees:
80
Headquarters:
Cambridge
IPO:
Went Public on Mar 28, 2014
Stock:
HZD
Categories:
Biotechnology
Description:
Horizon Discovery is a translational genomics company developing patient-relevant drug discovery and diagnostic research tools.

Detailed Description

Update

Horizon Discovery is a UK Biotechnology company that combines a long scientific heritage in translational research with GENESIS™, a precision gene-editing platform that incorporates rAAV, CRISPR and ZFN technologies. The company supplies genetically-defined cell lines, gene-editing tools and services, custom cell line generation, reporter gene assay kits, molecular reference standards and assay development and screening services to approaching 1,000 organizations engaged in academic research; drug discovery and development, clinical diagnostics, and biopharmaceutical process optimization. Horizon aspires to provide science-driven research solutions that lead to the advancement in the understanding of the genetic basis of disease and better outcomes for patients.

Current Team (18)

Update

Past Team (1)

Update

Investors (13)

Update

Offices/Locations (1)

Update
  • Cambridge HQ

    7100 Cambridge Research Park

    Waterbeach

    Cambridge, CB25 9TL

    GBR

Images (2)

Update
  • 2001cf00b34e32b6dd0679b367936e8f
  • Ab004b693a8ddcb37d4f8b9cefd05a2c